JC
ABBV icon

JB Capital’s AbbVie ABBV Stock Holding History

JB Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79M Sell
7,111
-4,169
-37% -$897K 0.06% 116
2026
Q1 		$2.45M Sell
11,280
-5,633
-33% -$1.25M 0.1% 101
2025
Q4 		$3.86M Buy
16,913
+12,338
+270% +$2.81M 0.16% 66
2025
Q3 		$1.06M Buy
4,575
+20
+0.4% +$4.07K 0.05% 133
2025
Q2 		$846K Sell
4,555
-49
-1% -$9.11K 0.04% 136
2025
Q1 		$965K Buy
4,604
+385
+9% +$74.8K 0.05% 118
2024
Q4 		$750K Sell
4,219
-109
-3% -$20K 0.04% 125
2024
Q3 		$855K Sell
4,328
-560
-11% -$105K 0.05% 124
2024
Q2 		$839K Buy
4,888
+36
+0.7% +$5.96K 0.05% 119
2024
Q1 		$884K Buy
4,852
+119
+3% +$20.5K 0.06% 112
2023
Q4 		$733K Buy
4,733
+275
+6% +$40.1K 0.05% 115
2023
Q3 		$665K Sell
4,458
-156
-3% -$22.9K 0.06% 109
2023
Q2 		$622K Sell
4,614
-128
-3% -$18.8K 0.05% 102
2023
Q1 		$756K Sell
4,742
-166
-3% -$25.4K 0.07% 86
2022
Q4 		$793K Sell
4,908
-164
-3% -$25.1K 0.08% 85
2022
Q3 		$681K Sell
5,072
-28,458
-85% -$4.08M 0.07% 87
2022
Q2 		$5.13M Sell
33,530
-17,601
-34% -$2.69M 0.55% 28
2022
Q1 		$8.29M Sell
51,131
-1,883
-4% -$274K 0.81% 19
2021
Q4 		$7.18M Buy
53,014
+2,889
+6% +$341K 0.7% 22
2021
Q3 		$5.41M Buy
+50,125
New +$5.73M 0.7% 20

Other funds holding ABBV

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

JB Capital's ABBV Position: Q2 2026 in Review

JB Capital reduced its AbbVie (ABBV) stake by 37% in Q2 2026, selling an estimated $897K and leaving 7,111 shares worth $1.79M. The position accounts for 0.06% of the portfolio, ranked #116.

JB Capital first reported a position in ABBV in Q3 2021 and has held it in 20 quarters since. The position peaked at $8.29M in Q1 2022. 2,493 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • JB Capital held 7,111 shares of AbbVie worth $1.79M as of Q2 2026.
  • JB Capital sold 4,169 AbbVie shares in Q2 2026, an estimated $897K.
  • AbbVie made up 0.06% of JB Capital's portfolio in Q2 2026, its #116 holding.
  • JB Capital first reported a position in AbbVie in Q3 2021 and has held it in 20 quarters since.
  • JB Capital's AbbVie position peaked at $8.29M in Q1 2022.
  • 2,493 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on JB Capital's 13F filing for Q2 2026, filed 29 Jul 2026.